BRPI0108478B8 - composição nutritiva contendo substancias pré-bióticas - Google Patents

composição nutritiva contendo substancias pré-bióticas

Info

Publication number
BRPI0108478B8
BRPI0108478B8 BRPI0108478A BR0108478A BRPI0108478B8 BR PI0108478 B8 BRPI0108478 B8 BR PI0108478B8 BR PI0108478 A BRPI0108478 A BR PI0108478A BR 0108478 A BR0108478 A BR 0108478A BR PI0108478 B8 BRPI0108478 B8 BR PI0108478B8
Authority
BR
Brazil
Prior art keywords
nutritional composition
composition containing
prebiotic substances
containing prebiotic
substances
Prior art date
Application number
BRPI0108478A
Other languages
English (en)
Other versions
BRPI0108478B1 (pt
BR0108478A (pt
Inventor
L Wilson Jeffrey
Original Assignee
Nestec Sa
Nestle Sa
Wyeth Corp
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24012783&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0108478(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa, Nestle Sa, Wyeth Corp, Wyeth Llc filed Critical Nestec Sa
Publication of BR0108478A publication Critical patent/BR0108478A/pt
Publication of BRPI0108478B1 publication Critical patent/BRPI0108478B1/pt
Publication of BRPI0108478B8 publication Critical patent/BRPI0108478B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/203—Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)
  • Fodder In General (AREA)

Abstract

"formulação nutritiva contendo substâncias pré-bióticas". uma composição nutritiva é proporcionada, que compreende oligofrutose e sialilactose.
BRPI0108478A 2000-02-17 2001-02-15 composição nutritiva contendo substancias pré-bióticas BRPI0108478B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50600900A 2000-02-17 2000-02-17
PCT/US2001/004794 WO2001060346A2 (en) 2000-02-17 2001-02-15 Nutritional formulation containing prebiotic substances

Publications (3)

Publication Number Publication Date
BR0108478A BR0108478A (pt) 2003-04-22
BRPI0108478B1 BRPI0108478B1 (pt) 2017-05-30
BRPI0108478B8 true BRPI0108478B8 (pt) 2021-05-25

Family

ID=24012783

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0108478A BRPI0108478B8 (pt) 2000-02-17 2001-02-15 composição nutritiva contendo substancias pré-bióticas

Country Status (13)

Country Link
EP (1) EP1255449B2 (pt)
JP (1) JP2003522784A (pt)
CN (1) CN1229115C (pt)
AR (1) AR027450A1 (pt)
AT (1) ATE357854T1 (pt)
AU (1) AU2001238285A1 (pt)
BR (1) BRPI0108478B8 (pt)
CA (1) CA2400737C (pt)
DE (1) DE60127533D1 (pt)
MX (1) MXPA02008016A (pt)
PT (1) PT1255449E (pt)
TW (1) TWI265008B (pt)
WO (1) WO2001060346A2 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1243273A1 (en) * 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
CN1703149A (zh) * 2002-10-11 2005-11-30 惠氏公司 包含共生菌物质的营养性配方制剂
US7951410B2 (en) * 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
US7867541B2 (en) * 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
WO2004112512A1 (en) 2003-06-23 2004-12-29 Nestec S.A. Amino acid supplementation for a healthy microbiota ecosystem
US20050287247A1 (en) * 2003-09-18 2005-12-29 Sorensen Esben S Infant formula
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
US7973021B2 (en) 2005-09-22 2011-07-05 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Immunomodulating agent in gut
JP2009514511A (ja) * 2005-11-04 2009-04-09 アルラ フーズ アンバ 天然のシアリルラクトースを濃縮した、乳製品由来の濃縮物及び、その調製方法
JP5268916B2 (ja) * 2008-03-27 2013-08-21 森永乳業株式会社 酸性乳酸菌飲料、酸性乳酸菌飲料の製造方法、およびビフィズス菌の生残性改善方法
KR101116864B1 (ko) * 2008-08-01 2012-02-29 주식회사 베네비오 고지혈증, 지방간 또는 비만의 예방 또는 치료용 조성물
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CA2752800C (en) 2009-02-24 2017-12-05 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
NL2004200C2 (en) * 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides in weight management.
NL2004201C2 (en) 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides to modulate the immune system.
WO2011136636A1 (en) * 2010-04-27 2011-11-03 N.V. Nutricia Use of 6'-sialyl lactose in infant nutrition
CN102858191A (zh) * 2010-04-27 2013-01-02 N.V.努特里奇亚 6’-唾液酸化乳糖在婴儿和幼儿营养物中的用途
CN103369974A (zh) 2010-12-31 2013-10-23 雅培制药有限公司 包含人乳低聚糖和长链多不饱和脂肪酸的营养型制剂以及其用途
EP3335577A1 (en) * 2010-12-31 2018-06-20 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
NZ612504A (en) 2010-12-31 2015-02-27 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
EP2658399B2 (en) 2010-12-31 2024-02-28 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides for use in treating and/or preventing enteric rotavirus infection
MX355780B (es) 2010-12-31 2018-04-30 Abbott Lab Fórmula pediátrica sintética para estimular células nerviosas entéricas en el tracto gastrointestinal.
EP2658547A1 (en) 2010-12-31 2013-11-06 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
CN110051676A (zh) 2010-12-31 2019-07-26 雅培制药有限公司 用于调节炎症的人乳寡糖
CA2822495C (en) 2010-12-31 2020-12-22 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
ES2692533T3 (es) † 2011-02-10 2018-12-04 Nestec S.A. Modulación del crecimiento de las bífidobacterias mediante una combinación de oligosacáridos de la leche humana
TR201809987T4 (tr) 2011-06-20 2018-08-27 Heinz Co Brands H J Llc Probiyotik bileşimler ve yöntemler.
BR112014004772A2 (pt) 2011-08-29 2017-03-21 Abbott Lab oligossacarídeos do leite humano para evitar danos e/ou promover a cura do trato gastrointestinal
NL2007931C2 (en) 2011-12-07 2013-06-10 Friesland Brands Bv Methods for providing sialylated oligosaccharides and products obtainable thereby.
EP3182841A1 (en) * 2014-08-18 2017-06-28 Nestec S.A. Prebiotics for reducing the risk of obesity later in life

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5953834B2 (ja) * 1982-05-19 1984-12-27 明治製菓株式会社 ビフイズス菌増殖促進物質
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
HU9502497D0 (en) * 1993-02-26 1995-10-30 Normark Use of oligosaccharide glycosides as inhibitors of bacterial adherence
JPH07258093A (ja) * 1994-03-23 1995-10-09 Morinaga Milk Ind Co Ltd 神経成長因子様剤
JP3501415B2 (ja) * 1994-03-30 2004-03-02 雪印乳業株式会社 ビフィズス菌および乳酸菌増殖促進剤
CN1129524A (zh) * 1994-09-09 1996-08-28 哈尔滨松花江第二乳品厂 婴幼儿阶段奶粉
US5849324A (en) * 1995-07-10 1998-12-15 Abbott Laboratories Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
US5827526A (en) † 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
WO1999064022A1 (en) * 1998-06-10 1999-12-16 Crum Albert B Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system
NZ510643A (en) * 1998-08-21 2002-06-28 Advanced Nutritional Foods Pty Composition of calcium and an oligosaccharide

Also Published As

Publication number Publication date
EP1255449A2 (en) 2002-11-13
WO2001060346A2 (en) 2001-08-23
MXPA02008016A (es) 2002-11-29
BRPI0108478B1 (pt) 2017-05-30
WO2001060346A3 (en) 2002-01-17
AR027450A1 (es) 2003-03-26
BR0108478A (pt) 2003-04-22
EP1255449B2 (en) 2016-06-08
CN1229115C (zh) 2005-11-30
DE60127533D1 (de) 2007-05-10
AU2001238285A1 (en) 2001-08-27
TWI265008B (en) 2006-11-01
ATE357854T1 (de) 2007-04-15
CN1406111A (zh) 2003-03-26
JP2003522784A (ja) 2003-07-29
CA2400737A1 (en) 2001-08-23
EP1255449B1 (en) 2007-03-28
PT1255449E (pt) 2007-08-24
CA2400737C (en) 2010-12-14

Similar Documents

Publication Publication Date Title
BRPI0108478B8 (pt) composição nutritiva contendo substancias pré-bióticas
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
BRPI0402760A (pt) Composição microbicida
HUP0402003A3 (en) Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
BR0015188A (pt) Composições farmacêuticas
HK1061037A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
IL155196A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
BR9710731A (pt) Dispensador interativo para produtos quimicos de uso pessoal ou produtos quimicos de cuidado pessoal que proporciona uma mensagem acionada pela proximidade do usu rio
AR025247A1 (es) Composiciones de granulos de carotenos-xantofilos, estables
ECSP045154A (es) Composiciones de fórmula para infantes que comrende cantidades aumentadas de alfa - lactalbumin
PT1112266E (pt) 4-amino-2-aril-pirimidinas substituidas, sua preparacao, sua utilizacao e composicoes farmaceuticas que as contem.
PT994710E (pt) Composicoes farmaceuticas administraveis por via oral incluindo uma benzidrilpiperazina e uma ciclodextrina
NO20020676L (no) Oral administreringsform som inneholder probiotiske mikroorganismer
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
HUP0103381A3 (en) Disubstituted maleimide compounds and medicinal utilization thereof and the pharmaceutical compositions containing the same
IL150905A0 (en) Andrographolide derivatives and pharmaceutical compositions containing the same
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
NO20012727D0 (no) 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme
CO5580729A2 (es) Composiciones nutricionales que comprenden cistationina
BR0011174A (pt) Composições, compostos, compostos isolados e métodos para controlar pestes
BR0213536A (pt) Formulações de xarope de ribavirina
DK1106174T3 (da) Sammensætninger der indeholder fedtoplöselige vitaminer

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA A CLASSIFICACAO DA INT. CL. : A61K 31/00 PARA INT. CL. :2010.1: A23L 1/09; A23L 1/30; A23L 1/302; A23C 9/152.

Ipc: A23L 1/09 (2010.01), A23L 1/30 (2010.01), A23L 1/3

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B25C Requirement related to requested transfer of rights

Owner name: WYETH (US)

Free format text: A FIM DE ATENDER A TRANSFERENCIA, REQUERIDA ATRAVES DA PETICAO NO 860130004992 DE 18/10/2013, E NECESSARIO ESCLARECER A DIVERGENCIA ENTRE O NOME DA EMPRESA TITULAR DO PEDIDO E O NOME DA EMPRESA CEDENTE.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 10 DA LPI.

B25D Requested change of name of applicant approved

Owner name: WYETH LLC (US)

B25A Requested transfer of rights approved

Owner name: NESTEC S.A (CH)

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23C 9/13 (2006.01), A23C 9/20 (2006.01), A23L 29/

B25A Requested transfer of rights approved
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/02/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 15/02/2021